Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1250-1256

  Cetin, Meltem ^a   Atila, Alptug ^a   Kadioglu, Yucel ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

Author keywords

diclofenac sodium; Eudragit L100; nanoparticles; PLGA; polymer blend

Indexed keywords

DICLOFENAC; EUDRAGIT; NANOPARTICLE; POLYGLACTIN;

ARTICLE; ATOMIC FORCE MICROSCOPY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; IN VITRO STUDY; PARTICLE SIZE; PH; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DIFFUSION; DRUG COMPOUNDING; LACTIC ACID; NANOCAPSULES; POLYGLYCOLIC ACID; POLYMETHACRYLIC ACIDS;

EID: 78649908528     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9489-6     Document Type: Article

References (42)

1. KS Soppimath TM Aminabhavi AR Kulkarni WE Rudzinski 2001 Biodegradable polymeric nanoparticles as drug delivery devices J Contr Release 70 1-2 1 20 10.1016/S0168-3659(00)00339-4 (Pubitemid 32144788)
2. Serda RE, Godin B, Blanco E, Chiappini C, Ferrari M. Multi-stage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta. 2010 (in press).
3. A Kumari SK Yadav SC Yadav 2010 Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf B Biointerfaces 75 1 1 18 10.1016/j.colsurfb.2009.09.001 19782542
4. SK Lai YY Wang J Hanes 2009 Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv Drug Deliv Rev 61 2 158 171 10.1016/j.addr.2008.11.002 19133304
5. SA Galindo-Rodriguez E Allemann H Fessi E Doelker 2005 Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies Crit Rev Ther Drug Carrier Syst 22 5 419 464 16313233
6. YJ Yamanaka KW Leong 2008 Engineering strategies to enhance nanoparticle-mediated oral delivery J Biomater Sci Polym Ed 19 12 1549 1570 10.1163/156856208786440479 19017470
7. TD Warner I Vojnovic D Bishop-Bailey JA Mitchell 2006 Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2 FASEB J 20 3 542 544 16403783
8. JA Mitchell TD Warner 1999 Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy Br J Pharmacol 128 6 1121 1132 10.1038/sj.bjp.0702897 10578123
9. MM Sena ZF Chaudhry CH Collins RJ Poppi 2004 Direct determination of diclofenac in pharmaceutical formulations containing B vitamins by using UV spectrophotometry and partial least squares regression J Pharm Biomed Anal 36 4 743 749 10.1016/j.jpba.2004.08.001 15533666 (Pubitemid 39469413)
10. M González J Rieumont D Dupeyron I Perdomo E Fernandez L Abdón, et al. 2008 Nanoencapsulation of acetyl salicylic acid within enteric polymer nanopaticles Rev Adv Mater Sci. 17 71 75
11. ZZ Piao MK Lee BJ Lee 2008 Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex Int J Pharm 350 1-2 205 211 10.1016/j.ijpharm.2007.08.044 17928177
12. RI Moustafine EB Margulis LF Sibgatullina VA Kemenova G Van den Mooter 2008 Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery Eur J Pharm Biopharm 70 1 215 225 10.1016/j.ejpb.2008.04.008 18691856
13. M Saffari M Shahbazi MS Ardestani 2008 Formulation and in vitro evaluation of Eudragit L100® microspheres of piroxicam Nat Precedings 1544 1 1 5
14. GP Andrews DS Jones OA Diak CP McCoy AB Watts JW McGinity 2008 The manufacture and characterisation of hot-melt extruded enteric tablets Eur J Pharm Biopharm 69 1 264 273 10.1016/j.ejpb.2007.11.001 18164604
15. PV Devarajan GS Sonavane 2007 Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin Pharmazie 63 10 736 742
16. PV Devarajan GS Sonavane 2007 Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as sustained release carriers Drug Dev Ind Pharm 33 2 101 111 10.1080/03639040601096695 17454041 (Pubitemid 46568294)
17. Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press and American Pharmacists Association; 2006.
18. F Mohamed CF van der Walle 2008 Engineering biodegradable polyester particles with specific drug targeting and drug release properties J Pharm Sci 97 1 71 87 10.1002/jps.21082 17722085
19. K Dillen C Bridts P Van der Veken P Cos J Vandervoort K Augustyns, et al. 2008 Adhesion of PLGA or Eudragit/PLGA nanoparticles to staphylococcus and pseudomonas Int J Pharm 349 1-2 234 240 10.1016/j.ijpharm.2007.07.041 17888598
20. N Jawahar T Eagappanath V Nagasamy S Jubie MK Samanta 2009 Preparation and characterisation of PLGA-nanoparticles containing an Anti-hypertensive agent Int J Pharm Tech Res 1 2 390 393
21. X Song Y Zhao S Hou F Xu R Zhao J He, et al. 2008 Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency Eur J Pharm Biopharm 69 2 445 453 10.1016/j.ejpb.2008.01.013 18374554
22. M Cetin Y Aktas I Vural Y Capan LA Dogan M Duman, et al. 2007 Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles Drug Deliv 14 8 525 529 10.1080/10717540701606483 18027182 (Pubitemid 350135855)
23. International Conference on Harmonization (ICH), Q2b: Validation of analytical procedures: methodology. US FDA Federal Register; 1997 (Vol. 62): p. 27463
24. M Hombreiro Pérez C Zinutti A Lamprecht N Ubrich A Astier M Hoffman, et al. 2000 The preparation and evaluation of poly(epsilon- caprolactone) microparticles containing both a lipophilic and a hydrophilic drug J Contr Release 65 3 429 438 10.1016/S0168-3659(99)00253-9 (Pubitemid 30122944)
25. M Cetin Y Capan I Vural AL Dogan D Guc AA Hincal, et al. 2005 Preparation and characterization of bFGF and BSA loaded microspheres J Drug Deliv Sci Tech 15 5 371 375
26. RC Mundargi S Srirangarajan SA Agnihotri SA Patil S Ravindra SB Setty, et al. 2007 Development and evaluation of novel biodegradable microspheres based on poly(d, l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies J Control Release 119 1 59 68 10.1016/j.jconrel.2007.01.008 17331611 (Pubitemid 46561539)
27. SS D'Souza PP DeLuca 2006 Methods to assess in vitro drug release from injectable polymeric particulate systems Pharm Res 23 3 460 474 10.1007/s11095-005-9397-8 16400516
28. M Kouchak F Atyabi 2004 Ion exchange, an approach to prepare an oral floating drug delivery system for diclofenac Iran J Pharm Res 2 93 97
29. M Tunçay S Caliş HS Kaş MT Ercan I Peksoy AA Hincal 2000 Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation Int J Pharm 195 1-2 179 188 10.1016/S0378-5173(99)00394-4 10675695 (Pubitemid 30089502)
30. AC Kilic Y Capan I Vural RN Gursoy T Dalkara A Cuine, et al. 2005 Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain J Microencapsul 22 6 633 641 10.1080/02652040500162766 16401579 (Pubitemid 43102159)
31. V Saxena M Sadoqi J Shao 2004 Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release Int J Pharm 278 2 293 301 10.1016/j.ijpharm.2004.03.032 15196634 (Pubitemid 38759502)
32. Sahoo SK, Labhasetwar V. Nanoparticles interface: an important determinant in nanoparticle-mediated drug/gene delivery. In: Gupta RB, Kompella UB, editors. Nanoparticle technology for drug delivery. New York: Taylor & Francis Group; 2006. p. 139-54.
33. I Bala V Bhardwaj S Hariharan SV Kharade N Roy MN Ravi Kumar 2006 Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration J Drug Target 14 1 27 34 10.1080/10611860600565987 16603449
34. YN Konan R Cerny J Favet M Berton R Gurny E Allémann 2003 Preparation and characterization of sterile sub-200 nm meso-tetra(4- hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy Eur J Pharm Biopharm 55 1 115 124 10.1016/S0939-6411(02)00128-5 12551712 (Pubitemid 36120503)
35. Fattal E, Quaglia F, Gupta P, Brazeau G. Biodegradable microparticles for the development of less-painful and less-irritating parenterals. In: Gupta P, Brazeau G, editors. Injectable Drug Development: Techniques to Reduce Pain and Irritation. Informa Health Care; 1999. p. 355-78.
36. C Wischke SP Schwendeman 2008 Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles Int J Pharm 364 2 298 327 10.1016/j.ijpharm. 2008.04.042 18621492
37. HS Choi SA Seo G Khang JM Rhee HB Lee 2002 Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles Int J Pharm 234 1-2 195 203 10.1016/S0378-5173(01)00968-1 11839450 (Pubitemid 34142624)
38. T Musumeci CA Ventura I Giannone B Ruozi L Montenegro R Pignatello, et al. 2006 PLA/PLGA nanoparticles for sustained release of docetaxel Int J Pharm 325 1-2 172 179 10.1016/j.ijpharm.2006.06.023 16887303 (Pubitemid 44573694)
39. SY Lin KS Chen HH Teng MJ Li 2000 In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters J Microencapsul 17 5 577 586 10.1080/026520400417630 11038117
40. J Dai T Nagai X Wang T Zhang M Meng Q Zhang 2004 pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A Int J Pharm 280 1-2 229 240 10.1016/j.ijpharm.2004.05.006 15265562 (Pubitemid 38950919)
41. BM Al-Taani BM Tashtoush 2003 Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium AAPS J Pharm Sci Tech 4 3 E43
42. BV Basavaraj R Deveswaran S Bharath S Abraham S Furtado V Madhavan 2008 Hollow microspheres of diclofenac sodium-a gastroretentive controlled delivery system Pak J Pharm Sci 21 4 451 454